Skip to main content
Year archive

AVACTA GROUP PLC — 2026 filings

All 20 regulatory filings released by AVACTA GROUP PLC (AVCT) in 2026, sourced directly from the official regulator.

20 Filings
2026 Period
2026 filings (20)
Filing Released Lang
Notice of Preliminary Results and Presentation
Report Publication Announcement
2026-05-13 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2026-05-13 English
Pre|CISION® payload release vs approved ADCs
Regulatory Filings
2026-05-06 English
Block Listing Six Monthly Return
Regulatory Filings
2026-04-28 English
Avacta data AACR underline AVA6103 profile
Regulatory Filings
2026-04-21 English
Q1 2026 Business Update
Regulatory Filings
2026-04-09 English
Avacta Announces Science Day 2026
Regulatory Filings
2026-04-08 English
First patient treated in Phase 1 trial of AVA6103
Regulatory Filings
2026-03-31 English
Result of Oversubscribed Fundraise
Capital/Financing Update
2026-03-27 English
Proposed Fundraise to raise approximately £10m
Share Issue/Capital Change
2026-03-26 English
Issue of Equity
Capital/Financing Update
2026-03-26 English
Presentations of pre|CISION® Platform Candidates
Regulatory Filings
2026-03-17 English
Phase 1 study opening for AVA6103
Regulatory Filings
2026-03-16 English
PreCISION payload delivery advantage over ADC
Regulatory Filings
2026-02-24 English
Avacta to Participate in Conference March 2026
Regulatory Filings
2026-02-18 English
Appointment of CSO
Board/Management Information
2026-02-09 English
Faridoxorubicin Program Clinical Updates
Regulatory Filings
2026-02-03 English
FDA Clearance of IND Application for AVA6103
Regulatory Filings
2026-01-21 English
Year-end trading update
Regulatory Filings
2026-01-20 English
Appointment of Nominated Adviser & TVR
Regulatory Filings
2026-01-20 English